GL1X · GenesisL1 explorer

Research workbench

Complement factor D in complex with a reversible benzoic acid based inhibitor

Analyse Complement factor D in complex with a reversible benzoic acid based inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5MT4
Type
protein
Length
228 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Complement factor D
EC
3.4.21.46
UniProt
P00746
Ligands
M7O
Pockets
1 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 8% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AComplement factor D (EC 3.4.21.46)protein2288% helix, 36% strandP00746

Ligands and binding sites

  • M7O · 2-[(phenylmethyl)carbamoylamino]benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11320.460.7827M7O

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5MT4 · Complement factor D in complex with a reversible benzoic acid based inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P00746 · AlphaFold monomer V2.0 prediction for complement factor D (P00746) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.